MaryGrace Stephenson
Ready to write your story
recent posts
about
Author: mstephenson0805
-
Financial institutions stand to gain $200–340 billion in annual value from AI investments, but their legacy infrastructure often gets in the way. While fintech startups build on modern tech stacks, established banking, financial services, and insurance (BFSI) organizations must find a path to AI innovation without disrupting decades of critical infrastructure investment. A recent survey by Turing,…
-
In the rapidly evolving world of technology, AI is no longer just a buzzword; it’s the most disruptive technological innovation of the 21st century. According to a 2024 McKinsey report, 70% of companies are already harnessing AI to streamline operations and enhance decision-making processes, demonstrating its profound impact across industries. Among those at the forefront of…
-
On December 12, 2024, the third installment of our AGI Icons series was held in Vancouver. The event featured Jeff Dean, Chief Scientist of Google DeepMind and Google Research, and Jonathan Siddharth, Co-Founder and CEO of Turing. Turing’s AGI Icons series is designed to bring together AI’s leading minds and host deep dialogues on the…
-
AI is no longer a distant concept—it’s becoming the foundation of what we build, how we work, and what’s possible to achieve—and it’s not slowing down. With 82% of companies already using or planning to integrate AI solutions, the demand for skilled and knowledgeable “AI professionals” has never been higher. The umbrella for who qualifies as an…
-
Model evaluation has emerged as a critical tool to enhance LLM’s performance and ROI. By systematically identifying inefficiencies, uncovering growth opportunities, and providing predictive analytics, model evaluation can significantly impact a model’s performance, keeping it on track with its intended purpose and improving effectiveness and reliability. However, a one-size-fits-all approach to model evaluation is ineffective.…
-
One forecast indicates that more than 262.9 to 446.2 million people live with a rare disease worldwide. To develop safe and effective treatments, sponsors and CROs must navigate unique concerns while reducing participant burden, ultimately accelerating ethical, groundbreaking research. In this article, we answer the questions: To explore innovative trial design and supply chain strategies specific to…
-
Every person who wants to participate in clinical research should have the opportunity to do so safely. Beyond that, their participation should be with the knowledge that their basic rights and well-being are protected, and all research has been done to provide the best possible outcome. Although most clinical research is governed by those fundamental rights, that…
-
It’s 2022—over one hundred years have passed since the women’s suffrage movement; women make up more than half of the college-educated workforce; and the U.S. has our first female Vice President. But, many of us continue to ask, “Is that enough?” (Hint: the answer is a resounding NO!) In anticipation of International Women’s Day on…
MaryGrace Stephenson 